Literature DB >> 3023943

Mutational analysis of a ras catalytic domain.

B M Willumsen, A G Papageorge, H F Kung, E Bekesi, T Robins, M Johnsen, W C Vass, D R Lowy.   

Abstract

We used linker insertion-deletion mutagenesis to study the catalytic domain of the Harvey murine sarcoma virus v-rasH transforming protein, which is closely related to the cellular rasH protein. The mutants displayed a wide range of in vitro biological activity, from those that induced focal transformation of NIH 3T3 cells with approximately the same efficiency as the wild-type v-rasH gene to those that failed to induce any detectable morphologic changes. Correlation of transforming activity with the location of the mutations enabled us to identify three nonoverlapping segments within the catalytic domain that were dispensable for transformation and six other segments that were required for transformation. Segments that were necessary for guanosine nucleotide (GDP) binding corresponded to three of the segments that were essential for transformation; two of the three segments share strong sequence homology with other purine nucleotide-binding proteins. Loss of GDP binding was associated with apparent instability of the protein. Lesions in two of the three other required regions significantly reduced GDP binding, while small lesions in the last required region did not impair GDP binding or membrane localization. We speculate that this latter region interacts with the putative cellular target of ras. The results suggest that transforming ras proteins require membrane localization, guanosine nucleotide binding, and an additional undefined function that may represent interaction with their target.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023943      PMCID: PMC367821          DOI: 10.1128/mcb.6.7.2646-2654.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

Authors:  J B Gibbs; I S Sigal; M Poe; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

Review 2.  Oncogenes and cancer: the p21 ras genes.

Authors:  T Y Shih; M O Weeks
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

3.  Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.

Authors:  L S Mulcahy; M R Smith; D W Stacey
Journal:  Nature       Date:  1985 Jan 17-23       Impact factor: 49.962

4.  Functional homology of mammalian and yeast RAS genes.

Authors:  T Kataoka; S Powers; S Cameron; O Fasano; M Goldfarb; J Broach; M Wigler
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

5.  Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli.

Authors:  V Manne; S Yamazaki; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  The p21 ras C-terminus is required for transformation and membrane association.

Authors:  B M Willumsen; A Christensen; N L Hubbert; A G Papageorge; D R Lowy
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

7.  Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins.

Authors:  J C Lacal; E Santos; V Notario; M Barbacid; S Yamazaki; H Kung; C Seamans; S McAndrew; R Crowl
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

8.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

9.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

10.  Harvey murine sarcoma virus p21 ras protein: biological and biochemical significance of the cysteine nearest the carboxy terminus.

Authors:  B M Willumsen; K Norris; A G Papageorge; N L Hubbert; D R Lowy
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

View more
  62 in total

1.  The structure of the carboxyl terminus of the p21 protein. Structural relationship to the nucleotide-binding/transforming regions of the protein.

Authors:  P W Brandt-Rauf; R P Carty; J M Chen; G Lee; S Rackovsky; M R Pincus
Journal:  J Protein Chem       Date:  1990-04

2.  GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites.

Authors:  A Valencia; M Kjeldgaard; E F Pai; C Sander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Identification of a nucleotide exchange-promoting activity for p21ras.

Authors:  J Downward; R Riehl; L Wu; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  A ras effector domain mutant which is temperature sensitive for cellular transformation: interactions with GTPase-activating protein and NF-1.

Authors:  J E DeClue; J C Stone; R A Blanchard; A G Papageorge; P Martin; K Zhang; D R Lowy
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Crystal structures of the small G protein Rap2A in complex with its substrate GTP, with GDP and with GTPgammaS.

Authors:  J Cherfils; J Ménétrey; G Le Bras; I Janoueix-Lerosey; J de Gunzburg; J R Garel; I Auzat
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

6.  Genetic definition of ras effector elements.

Authors:  J C Stone; R A Blanchard
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

7.  The murine N-ras gene is not essential for growth and development.

Authors:  H Umanoff; W Edelmann; A Pellicer; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Differential activation of yeast adenylyl cyclase by Ras1 and Ras2 depends on the conserved N terminus.

Authors:  N Hurwitz; M Segal; I Marbach; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Two types of RAS mutants that dominantly interfere with activators of RAS.

Authors:  V Jung; W Wei; R Ballester; J Camonis; S Mi; L Van Aelst; M Wigler; D Broek
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.